Plitidepsin in patients with advanced colorectal cancer (CRC): Results of an exploratory phase II trial

被引：0
|
作者：
Tabernero, Josep M.
Rivera, Fernando
Casado, Esther
Sanchez, Antonio
Bezares, Susana
Pico, Cesar
Paz-Ares, Luis
机构：
[1] Hosp Gen Valle Hebron, Barcelona, Spain
[2] Univ Marques Valdecilla, Santander, Spain
[3] Clin Puerta Hierro, Madrid, Spain
[4] PharmaMar SAU, Madrid, Spain
[5] Univ Madrid, Hosp 12 Octubre, Madrid 3, Spain
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [1] Plitidepsin in patients with advanced renal cancer (RCC):: Results of an exploratory phase II trial
    Climent, Miguel A.
    Schoffski, Patrick
    Paz-Ares, Luis
    Rivera, Fernando
    Bezares, Susana
    Pico, Cesar
    Tabernero, Josep M.
    ANNALS OF ONCOLOGY, 2006, 17 : 147 - 147
  • [2] A phase I/II trial of the multipeptide cancer vaccine IMA910 in patients with advanced colorectal cancer (CRC).
    Mayer, Frank
    Mayer-Mokler, Andrea
    Nowara, Elzbieta
    Torday, Laszlo
    Ludwig, Joerg
    Kuttruff, Sabrina
    Weinschenk, Toni
    Walter, Steffen
    Singh, Harpreet
    Reinhardt, Carsten
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] A phase II trial of irinotecan, 5-fluorouracil and leucovorin in patients with previously untreated advanced colorectal cancer (CRC)
    Lee, N.
    Bae, S.
    Lee, S.
    Kim, D.
    Kim, K.
    Kim, H.
    Kim, C.
    Lee, K.
    Won, J.
    Hong, D.
    Park, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Raltirexed (Tomudex), in elderly patients with advanced colorectal cancer (CRC): A phase II study.
    Comandone, A
    Oliva, C
    Dal Canton, O
    Boglione, A
    Cutin, SC
    Brizzi, MP
    Pochettino, P
    Bergnolo, P
    ANNALS OF ONCOLOGY, 2000, 11 : 57 - 57
  • [5] Phase II trial of irinotecan and capecitabine in patients with advanced colorectal cancer (ACRC)
    Ahn, JB
    Jung, KH
    Park, YS
    Kim, YH
    Chang, HJ
    Sohn, DK
    Lim, SB
    Choi, HS
    Jeong, SY
    Park, JG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 299S - 299S
  • [6] Phase I/II trial of gefitinib and oxaliplatin in patients with advanced colorectal cancer
    Kindler, HL
    Friberg, G
    Skoog, L
    Wade-Oliver, K
    Vokes, EE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (04): : 340 - 344
  • [7] Phase II study of S-1 in combination with irinotecan in patients with advanced colorectal cancer (CRC)
    Komatsu, Y
    Yuuki, S
    Amano, T
    Machida, N
    Ozasa, M
    Kato, T
    Furukawa, S
    Akita, H
    Asaka, M
    Sakata, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 297S - 297S
  • [8] Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort
    Anwaar Saeed
    Robin Park
    Harsh Pathak
    Ayah Nedal Al-Bzour
    Junqiang Dai
    Milind Phadnis
    Raed Al-Rajabi
    Anup Kasi
    Joaquina Baranda
    Weijing Sun
    Stephen Williamson
    Yu-Chiao Chiu
    Hatice Ulku Osmanbeyoglu
    Rashna Madan
    Hassan Abushukair
    Kelly Mulvaney
    Andrew K. Godwin
    Azhar Saeed
    Nature Communications, 15
  • [9] Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort
    Saeed, Anwaar
    Park, Robin
    Pathak, Harsh
    Al-Bzour, Ayah Nedal
    Dai, Junqiang
    Phadnis, Milind
    Al-Rajabi, Raed
    Kasi, Anup
    Baranda, Joaquina
    Sun, Weijing
    Williamson, Stephen
    Chiu, Yu-Chiao
    Osmanbeyoglu, Hatice Ulku
    Madan, Rashna
    Abushukair, Hassan
    Mulvaney, Kelly
    Godwin, Andrew K.
    Saeed, Azhar
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [10] CHARTA: FOLFOX plus bevacizumab plus /- irinotecan in advanced colorectal cancer (CRC)-Final results of the randomized phase II trial of the AIO (KRK 0209).
    Schmoll, Hans-Joachim
    Garlipp, Benjamin
    Junghanss, Christian
    Leithaeuser, Malte
    Vogel, Arndt
    Schaefers, Michael
    Kaiser, Ulrich
    Hoeffkes, Heinz-Gert
    Florschuetz, Axel
    Ruessel, Joern
    Kanzler, Stephan
    Edelmann, Thomas
    Forstbauer, Helmut
    Goehler, Thomas
    Hannig, Carla
    Hildebrandt, Bert
    Steighardt, Joerg
    Meinert, Fabian Maximilian
    Cygon, Franziska
    Stein, Alexander
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
12345